These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23037806)

  • 1. Mechanisms of action underlying the immunotherapeutic activity of Allovectin in advanced melanoma.
    Doukas J; Rolland A
    Cancer Gene Ther; 2012 Dec; 19(12):811-7. PubMed ID: 23037806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Velimogene aliplasmid.
    Soares HP; Lutzky J
    Expert Opin Biol Ther; 2010 May; 10(5):841-51. PubMed ID: 20367461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase 2 study of high-dose Allovectin-7 in patients with advanced metastatic melanoma.
    Bedikian AY; Richards J; Kharkevitch D; Atkins MB; Whitman E; Gonzalez R
    Melanoma Res; 2010 Jun; 20(3):218-26. PubMed ID: 20354459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic therapy targeting metastatic melanoma: allovectin-7.
    Chowdhery R; Gonzalez R
    Immunotherapy; 2011 Jan; 3(1):17-21. PubMed ID: 21174553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allovectin-7 therapy in metastatic melanoma.
    Bedikian AY; Del Vecchio M
    Expert Opin Biol Ther; 2008 Jun; 8(6):839-44. PubMed ID: 18476795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human gene therapy for melanoma: CT-guided interstitial injection.
    Waddill W; Wright W; Unger E; Stopeck A; Akporiaye E; Harris D; Grogan T; Schluter S; Hersh E; Stahl S
    AJR Am J Roentgenol; 1997 Jul; 169(1):63-7. PubMed ID: 9207502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma.
    Stopeck AT; Jones A; Hersh EM; Thompson JA; Finucane DM; Gutheil JC; Gonzalez R
    Clin Cancer Res; 2001 Aug; 7(8):2285-91. PubMed ID: 11489803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma.
    Stopeck AT; Hersh EM; Akporiaye ET; Harris DT; Grogan T; Unger E; Warneke J; Schluter SF; Stahl S
    J Clin Oncol; 1997 Jan; 15(1):341-9. PubMed ID: 8996161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional immunotherapy as a strategy to treat melanoma.
    Nouri N; Garbe C
    Expert Opin Biol Ther; 2016; 16(5):619-26. PubMed ID: 26898656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 2 trial of Allovectin-7 in advanced metastatic melanoma.
    Gonzalez R; Hutchins L; Nemunaitis J; Atkins M; Schwarzenberger PO
    Melanoma Res; 2006 Dec; 16(6):521-6. PubMed ID: 17119453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of direct intralesional gene transfer of HLA-B7 into metastatic renal carcinoma lesions.
    Rini BI; Selk LM; Vogelzang NJ
    Clin Cancer Res; 1999 Oct; 5(10):2766-72. PubMed ID: 10537340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technology evaluation: Allovectin-7, Vical.
    Galanis E
    Curr Opin Mol Ther; 2002 Feb; 4(1):80-7. PubMed ID: 11883699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of HLA-B7/beta-2 microglobulin plasmid DNA/lipid complex (Allovectin-7) in patients with metastatic melanoma.
    Bergen M; Chen R; Gonzalez R
    Expert Opin Biol Ther; 2003 Apr; 3(2):377-84. PubMed ID: 12662150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with HLA-B7 plasmid DNA/lipid complex in advanced squamous cell carcinoma of the head and neck.
    Gleich LL; Gluckman JL; Nemunaitis J; Suen JY; Hanna E; Wolf GT; Coltrera MD; Villaret DB; Wagman L; Castro D; Gapany M; Carroll W; Gillespie D; Selk LM
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):775-9. PubMed ID: 11448348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralesional therapy for advanced melanoma: promise and limitation.
    Agarwala SS
    Curr Opin Oncol; 2015 Mar; 27(2):151-6. PubMed ID: 25629369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloantigen gene therapy for squamous cell carcinoma of the head and neck: results of a phase-1 trial.
    Gleich LL; Gluckman JL; Armstrong S; Biddinger PW; Miller MA; Balakrishnan K; Wilson KM; Saavedra HI; Stambrook PJ
    Arch Otolaryngol Head Neck Surg; 1998 Oct; 124(10):1097-104. PubMed ID: 9776187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human melanoma cells transfected with the B7-2 co-stimulatory molecule induce tumor-specific CD8+ cytotoxic T lymphocytes in vitro.
    Imro MA; Dellabona P; Manici S; Heltai S; Consogno G; Bellone M; Rugarli C; Protti MP
    Hum Gene Ther; 1998 Jun; 9(9):1335-44. PubMed ID: 9650618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7.
    Rubin J; Galanis E; Pitot HC; Richardson RL; Burch PA; Charboneau JW; Reading CC; Lewis BD; Stahl S; Akporiaye ET; Harris DT
    Gene Ther; 1997 May; 4(5):419-25. PubMed ID: 9274718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the Tumor Reactivity of Tumor-Infiltrating Lymphocytes in a Metastatic Melanoma Lesion that Lost Major Histocompatibility Complex Class I Expression after Anti-PD-1 Therapy.
    Inozume T; Yaguchi T; Ariyasu R; Togashi Y; Ohnuma T; Honobe A; Nishikawa H; Kawakami Y; Kawamura T
    J Invest Dermatol; 2019 Jul; 139(7):1490-1496. PubMed ID: 30684558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for head and neck cancer.
    Gleich LL
    Laryngoscope; 2000 May; 110(5 Pt 1):708-26. PubMed ID: 10807351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.